Using the voluntary harmonisation procedure to apply for permission to conduct multinational clinical trials across the EU can, in some cases, lead to faster trial authorisations, compared with using the traditional application approach.
Neena Brizmohun, stating Delphine Decker
2012 – SCRIP Regulatory Affairs
All our resources
blog
2024 is here and will be a crucial year for your clinical trials in the European Union (EU) and European…
blog
The adoption of Electronic Patient-Reported Outcomes (ePRO) in clinical research marks a significant evolution in the way patient-centered data is…
webinar
Embracing an Early Access Program (EAP) presents a strategic avenue for creating valuable opportunities for patients and companies. This webinar…
whitepaper
There are multiple definitions associated with a registry and any future sponsors can feel anxious when it is time to…
